Canine cardiology study to be published this fall

Aug 15, 2008
By staff
St. Joseph, Mo. -- A three-year global canine cardiology study funded by Boehringer Ingelheim Animal Health that could reveal new information about congestive heart failure treatments has concluded.

The Quality of Life and Extension of Survival Time (QUEST) study compared two different treatments - pimobendan capsules vs. a benazepril hydrochloride treatment - for 260 dogs in 11 countries. The study looked at the effect both treatments had on the survival time in dogs suffering from congestive heart failure due to myxomatous mitral valve disease, according to researchers.

Results of the study are to be published in the fall edition of the Journal of Veterinary Internal Medicine.